A randomized doubled blinded trial of treatment with diamino-oxidase (DAO) in patients with migraine and deficit of enzyme'/INS;s activity

      Background: Histamine has been considerate as a chemical mediator of migraine. The degradation is done in two different pathways. One of the enzymes that allow this process is the diamino-oxidase (DAO).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect